Tomoki Nakamura

Lecturer

Mie university

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Tomoki Nakamura is a Lecturer at Mie University in Japan. His research focuses on sarcomas, particularly in the context of radiotherapy, inflammatory biomarkers, and novel therapeutic strategies. Recent articles authored by him explore topics such as the relationship between exosomal PD-L1 and radiotherapy, the prediction of survival in soft tissue sarcoma patients, and mechanisms of lung metastasis in osteosarcoma.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Ryohei Sasaki

Professor

Kobe University Hospital

JAPAN

View details

Tomohiro Fujiwara

Assistant Professor

Okayama University Hospital

JAPAN

View details

Akihiro Sudo

Mie university

JAPAN

View details

Hiroya Kondo

Okayama University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tomoki Nakamura

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Release of Exosomal PD-L1 in Bone and Soft Tissue Sarcomas and Its Relationship to Radiotherapy

The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study

A Novel Approach to Reducing Lung Metastasis in Osteosarcoma: Increasing Cell Stiffness with Carbenoxolone

Long-Term Results of Kyocera Modular Limb Salvage System after Resection of Tumors in the Distal Part of the Femur: Report from Japanese Musculoskeletal Oncology Group Study

Clinical Outcome of Patients with Pelvic and Retroperitoneal Bone and Soft Tissue Sarcoma: A Retrospective Multicenter Study in Japan

Is Lymphocyte C-Reactive Protein Ratio Useful for Predicting Survival in Patients with Non-Metastatic Soft Tissue Sarcoma?

GPR64, Screened from Ewing Sarcoma Cells, Is a Potential Target for Antibody-Based Therapy for Various Sarcomas

Sarcomas: New Biomarkers and Therapeutic Strategies

Cytoskeletal Actin Structure in Osteosarcoma Cells Determines Metastatic Phenotype via Regulating Cell Stiffness, Migration, and Transmigration

Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas

Collaborators (4)

Ryohei Sasaki

Tomohiro Fujiwara

Akihiro Sudo

Hiroya Kondo

Make your next move.